3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
5
Phase 2
2
Phase EARLY_PHASE1
1
Phase 2/3
1
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Mesothelioma, Malignant
1
Liposarcoma
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
7
Cyclophosphamide
6
pembrolizumab
5
Radiosurgery
5
Nivolumab
4
Fluorouracil
4
Carboplatin
4
Blood Specimen Collection
4
Biopsy
4
X-Rays
3
Vincristine
3
Surveys and Questionnaires
3
Proflavine
3
Positron-Emission Tomography
3
Metformin
3
Cisplatin
3
Bevacizumab
3
fludarabine phosphate
2
durvalumab
2
atezolizumab
2
Varenicline
2
Topotecan
2
Taxes
2
Specimen Handling
2
Rituximab
2
Radiotherapy
2
Positron Emission Tomography Computed Tomography
2
Oxaliplatin
2
Leucovorin
2
Letrozole
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Terminated
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled